Maryland HB 847: Prescription Drug Monitoring Program - Disclosure of Data - Managed Care Organizations

Status: Unfavorable Report by Health and Government Operations; Withdrawn (as of 2019-03-28)

State: Maryland · Session: 2019 · Bill: HB 847

Subjects: Public Health, Committees and Commissions, Communications, Data, Disclosure, Drugs, Examinations, Federal Government, Health Occupations, Investigations and Inquiries, Law Enforcement, Licenses, Managed Care Organizations, Medical Assistance, Medical Treatments, Opioids, Patients, Pharmacists and Pharmacies, Physicians, Privacy, Rules and Regulations, Subpoenas

Sponsors: R. Lewis and Cullison

View Maryland HB 847 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.